134 related articles for article (PubMed ID: 16985186)
1. The mechanism of activity-dependent sodium channel inhibition by the antidepressants fluoxetine and desipramine.
Lenkey N; Karoly R; Kiss JP; Szasz BK; Vizi ES; Mike A
Mol Pharmacol; 2006 Dec; 70(6):2052-63. PubMed ID: 16985186
[TBL] [Abstract][Full Text] [Related]
2. Sodium channel blockade may contribute to the analgesic efficacy of antidepressants.
Dick IE; Brochu RM; Purohit Y; Kaczorowski GJ; Martin WJ; Priest BT
J Pain; 2007 Apr; 8(4):315-24. PubMed ID: 17175203
[TBL] [Abstract][Full Text] [Related]
3. Direct inhibitory effect of fluoxetine on N-methyl-D-aspartate receptors in the central nervous system.
Szasz BK; Mike A; Karoly R; Gerevich Z; Illes P; Vizi ES; Kiss JP
Biol Psychiatry; 2007 Dec; 62(11):1303-9. PubMed ID: 17659262
[TBL] [Abstract][Full Text] [Related]
4. G protein-activated inwardly rectifying K+ channel inhibition and rescue of weaver mouse motor functions by antidepressants.
Takahashi T; Kobayashi T; Ozaki M; Takamatsu Y; Ogai Y; Ohta M; Yamamoto H; Ikeda K
Neurosci Res; 2006 Feb; 54(2):104-11. PubMed ID: 16310876
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neuronal Na+ channels by antidepressant drugs.
Pancrazio JJ; Kamatchi GL; Roscoe AK; Lynch C
J Pharmacol Exp Ther; 1998 Jan; 284(1):208-14. PubMed ID: 9435180
[TBL] [Abstract][Full Text] [Related]
6. A novel modulatory mechanism of sodium currents: frequency-dependence without state-dependent binding.
Mike A; Karoly R; Vizi ES; Kiss JP
Neuroscience; 2004; 125(4):1019-28. PubMed ID: 15120861
[TBL] [Abstract][Full Text] [Related]
7. Effect of fluoxetine on a neuronal, voltage-dependent potassium channel (Kv1.1).
Tytgat J; Maertens C; Daenens P
Br J Pharmacol; 1997 Dec; 122(7):1417-24. PubMed ID: 9421290
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization of sodium channel blockers by membrane potential measurements in cerebellar neurons: prediction of compound preference for the open/inactivated state.
Kolok S; Nagy J; Szombathelyi Z; Tarnawa I
Neurochem Int; 2006 Nov; 49(6):593-604. PubMed ID: 16777267
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of antidepressants on the NMDA-evoked [(3)H]noradrenaline release from rat hippocampal slices.
Mayer A; Szasz BK; Kiss JP
Neurochem Int; 2009 Nov; 55(6):383-8. PubMed ID: 19393275
[TBL] [Abstract][Full Text] [Related]
10. Effects of salicylate on voltage-gated sodium channels in rat inferior colliculus neurons.
Liu Y; Li X
Hear Res; 2004 Jul; 193(1-2):68-74. PubMed ID: 15219321
[TBL] [Abstract][Full Text] [Related]
11. GluN2B-containing NMDA receptors as possible targets for the neuroprotective and antidepressant effects of fluoxetine.
Kiss JP; Szasz BK; Fodor L; Mike A; Lenkey N; Kurkó D; Nagy J; Vizi ES
Neurochem Int; 2012 Jan; 60(2):170-6. PubMed ID: 22197911
[TBL] [Abstract][Full Text] [Related]
12. Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels.
Haeseler G; Foadi N; Ahrens J; Dengler R; Hecker H; Leuwer M
Pain; 2006 Dec; 126(1-3):234-44. PubMed ID: 16949748
[TBL] [Abstract][Full Text] [Related]
13. The effect of kappa-opioid receptor agonists on tetrodotoxin-resistant sodium channels in primary sensory neurons.
Su X; Castle NA; Antonio B; Roeloffs R; Thomas JB; Krafte DS; Chapman ML
Anesth Analg; 2009 Aug; 109(2):632-40. PubMed ID: 19608841
[TBL] [Abstract][Full Text] [Related]
14. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine.
Conti B; Maier R; Barr AM; Morale MC; Lu X; Sanna PP; Bilbe G; Hoyer D; Bartfai T
Mol Psychiatry; 2007 Feb; 12(2):167-89. PubMed ID: 17033635
[TBL] [Abstract][Full Text] [Related]
15. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.
Sheets PL; Heers C; Stoehr T; Cummins TR
J Pharmacol Exp Ther; 2008 Jul; 326(1):89-99. PubMed ID: 18378801
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs.
Thériault O; Poulin H; Beaulieu JM; Chahine M
Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311
[TBL] [Abstract][Full Text] [Related]
17. High-affinity blockade of voltage-operated skeletal muscle sodium channels by 2,6-dimethyl-4-chlorophenol.
Haeseler G; Gudehus S; Bufler J; Dengler R; Leuwer M
Eur J Anaesthesiol; 2006 Mar; 23(3):190-6. PubMed ID: 16430789
[TBL] [Abstract][Full Text] [Related]
18. Carisbamate, a novel neuromodulator, inhibits voltage-gated sodium channels and action potential firing of rat hippocampal neurons.
Liu Y; Yohrling GJ; Wang Y; Hutchinson TL; Brenneman DE; Flores CM; Zhao B
Epilepsy Res; 2009 Jan; 83(1):66-72. PubMed ID: 19013768
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the cardiac L-type calcium channel current by antidepressant drugs.
Zahradník I; Minarovic I; Zahradníková A
J Pharmacol Exp Ther; 2008 Mar; 324(3):977-84. PubMed ID: 18048694
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor.
Eisensamer B; Rammes G; Gimpl G; Shapa M; Ferrari U; Hapfelmeier G; Bondy B; Parsons C; Gilling K; Zieglgänsberger W; Holsboer F; Rupprecht R
Mol Psychiatry; 2003 Nov; 8(12):994-1007. PubMed ID: 14647397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
